Latest Monoclonal antibodies Stories
Natalizumab Was Well-Tolerated Under Double the Standard Dose Schedule NEW YORK, April 20, 2015 /PRNewswire-USNewswire/ -- Extending the dose of an infusion medication for multiple
INDIANAPOLIS, April 20, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the investigational medicine ixekizumab was statistically superior to placebo in the treatment
SAN DIEGO, April 18, 2015 /PRNewswire/ -- Sorrento Therapeutics, Inc.
DALLAS, April 17, 2015 /PRNewswire/ -- The report "Chromatography Resins Market in Drug Discovery by Technique (Ion Exchange, Affinity (Protein A, G & L), Hydrophobic
Creative Biolabs, a leading company in antibody production and engineering has introduced the latest in world leading DASS technology and De Novo Antibody sequencing services. New
PRINCETON, N.J., April 14, 2015 /PRNewswire/ -- Soligenix, Inc.
DALLAS, April 10, 2015 /PRNewswire/ -- Lifescienceindustryresearch.com adds Global & USA Cancer Immunotherapy Market Analysis to 2020 a new research report in its store.
SAN JOSE, Calif., April 9, 2015 /PRNewswire/ -- Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies
- An armed gangster.
More Images (1 images) »